Blog

Antibody fragments have become essential tools in modern therapeutic research, offering smaller size, higher tissue penetration, and improved stability compared to full-length antibodies. At Yaohai

In modern therapeutic development, many antibody programs start with an ScFv fragment due to its flexibility and historical usage. However, as projects progress toward clinical application,